citalopram has been researched along with mdl 100907 in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (63.64) | 29.6817 |
| 2010's | 6 (27.27) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Hatanaka, K; Yamaguchi, T; Yatsugi, S | 2 |
| Brocco, M; Girardon, S; Millan, MJ; Veiga, S | 1 |
| Audenaert, K; Blankaert, P; Dierckx, R; Gielen, I; Goethals, I; Hoybergs, Y; Otte, A; Peremans, K; van Heeringen, C; Vervaet, M | 1 |
| Hietala, J; Majasuo, H; Pälvimäki, EP; Syvälahti, E | 1 |
| Eckler, JR; Rabin, RA; Rice, KC; Winter, JC | 1 |
| Kuypers, KP; Ramaekers, JG; Wingen, M | 2 |
| Bosker, FJ; Cremers, TI; Hogg, S; Mørk, A; Rea, K; Westerink, BH; Wikström, HV | 1 |
| Hutson, PH; Murray, F | 1 |
| Caccia, S; Calcagno, E; Canetta, A; Cervo, L; Fracasso, C; Guzzetti, S; Invernizzi, RW | 1 |
| Blier, P; Dremencov, E; El Mansari, M | 1 |
| Aznar, S; Knudsen, GM; Licht, CL; Marcussen, AB; Overstreet, DH; Wegener, G | 1 |
| Gannon, RL; Millan, MJ; Peglion, JL | 1 |
| Aznar, S; El-Sayed, M; Elvang, AB; Ettrup, A; Holm, P; Klein, AB; Knudsen, GM; Mikkelsen, JD; Santini, MA; Stensbøl, TB | 1 |
| Calcagno, E; Invernizzi, RW | 1 |
| Furr, A; Lapiz-Bluhm, MD; Morilak, DA | 1 |
| Elliott, R; Hornboll, B; Knudsen, GM; Macoveanu, J; Paulson, OB; Rowe, J; Siebner, HR | 1 |
| Bessa, J; Doukas, D; Dulawa, SM; Kay, LJ; Klenotich, SC; Morais, M; Opal, MD; Sousa, N; Winkle, J | 1 |
| Bauer, EP; Bayat, L; Goldschmiedt, D; Pasik, SD; Pelrine, E | 1 |
| Baranowska-Kuczko, M; Göthert, M; Kloza, M; Kozłowska, H; Kozłowski, M; MacLean, MR; Malinowska, B; Sadowska, O; Schlicker, E | 1 |
| Andreasen, JT; Kristensen, JL; Odland, AU | 1 |
3 trial(s) available for citalopram and mdl 100907
| Article | Year |
|---|---|
Selective verbal and spatial memory impairment after 5-HT1A and 5-HT2A receptor blockade in healthy volunteers pre-treated with an SSRI.
Topics: Administration, Oral; Adult; Affect; Brain; Citalopram; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Ketanserin; Male; Mental Recall; Pindolol; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Reference Values; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Space Perception; Verbal Learning | 2007 |
The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers.
Topics: Administration, Oral; Adult; Attention; Citalopram; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Ketanserin; Male; Pindolol; Psychomotor Performance; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sleep | 2007 |
Acute serotonin 2A receptor blocking alters the processing of fearful faces in the orbitofrontal cortex and amygdala.
Topics: Adult; Amygdala; Anger; Citalopram; Facial Expression; Fear; Female; Frontal Lobe; Functional Neuroimaging; Healthy Volunteers; Humans; Ketanserin; Magnetic Resonance Imaging; Male; Neural Pathways; Photic Stimulation; Radioligand Assay; Reaction Time; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Sex Factors; Tryptophan; Visual Perception | 2013 |
19 other study(ies) available for citalopram and mdl 100907
| Article | Year |
|---|---|
Effect of acute treatment with YM992 on extracellular serotonin levels in the rat frontal cortex.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Cerebral Cortex; Citalopram; Cyclohexanols; Dose-Response Relationship, Drug; Extracellular Space; Fluorobenzenes; Fluoxetine; Frontal Lobe; Male; Morpholines; p-Chloroamphetamine; Piperidines; Rats; Rats, Wistar; Serotonin; Serotonin Agents; Serotonin Antagonists; Synaptosomes; Tritium; Venlafaxine Hydrochloride | 2000 |
Effect of acute treatment with YM992 on extracellular norepinephrine levels in the rat frontal cortex.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Citalopram; Cyclohexanols; Dose-Response Relationship, Drug; Extracellular Space; Fluorobenzenes; Fluoxetine; Frontal Lobe; Male; Morpholines; Norepinephrine; Piperidines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Venlafaxine Hydrochloride | 2000 |
Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.
Topics: Animals; Citalopram; Environment Design; Fluvoxamine; Injections, Subcutaneous; Male; Mice; Motor Activity; Movement Disorders; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists | 2003 |
The effect of citalopram hydrobromide on 5-HT2A receptors in the impulsive-aggressive dog, as measured with 123I-5-I-R91150 SPECT.
Topics: Aggression; Animals; Behavior, Animal; Brain; Citalopram; Dogs; Impulsive Behavior; Piperidines; Radiopharmaceuticals; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2005 |
Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
Topics: Amphetamines; Animals; Choroid Plexus; Citalopram; Dose-Response Relationship, Drug; Ergolines; Fluoxetine; Hydrolysis; Inositol Phosphates; Male; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Second Messenger Systems; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2005 |
Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram.
Topics: Aminopyridines; Analysis of Variance; Animals; Citalopram; Discrimination Learning; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Indoles; Male; Phencyclidine; Piperazines; Rats; Rats, Inbred F344; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2005 |
Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies.
Topics: Animals; Brain; Brain Chemistry; Citalopram; Depressive Disorder; Drug Administration Routes; Drug Synergism; gamma-Aminobutyric Acid; Hippocampus; Male; Microdialysis; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Synaptic Transmission | 2007 |
Hippocampal Bcl-2 expression is selectively increased following chronic but not acute treatment with antidepressants, 5-HT(1A) or 5-HT(2C/2B) receptor antagonists.
Topics: Amitriptyline; Analysis of Variance; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Citalopram; Fluorobenzenes; Hippocampus; Imipramine; Indoles; Male; Mice; Piperazines; Piperidines; Proto-Oncogene Proteins c-bcl-2; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sulfonamides | 2007 |
Enhancement of cortical extracellular 5-HT by 5-HT1A and 5-HT2C receptor blockade restores the antidepressant-like effect of citalopram in non-responder mice.
Topics: Aminopyridines; Analysis of Variance; Animals; Antidepressive Agents; Cerebral Cortex; Citalopram; Drug Interactions; Exploratory Behavior; Extracellular Fluid; Indoles; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Microdialysis; Piperazines; Pyridines; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2009 |
Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area.
Topics: Action Potentials; Aminopyridines; Analysis of Variance; Animals; Catheterization; Citalopram; Dopamine; Indoles; Male; Microelectrodes; Neurons; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Ventral Tegmental Area | 2009 |
The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration.
Topics: Animals; Antidepressive Agents, Second-Generation; Autoradiography; Brain; Citalopram; Depression; Disease Models, Animal; Fenclonine; Fenfluramine; Fluorobenzenes; Freezing Reaction, Cataleptic; Male; Paroxetine; Piperidines; Protein Binding; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT4; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Swimming; Time Factors; Tritium | 2009 |
Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: interaction studies with citalopram.
Topics: Animals; Circadian Rhythm; Citalopram; Cricetinae; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Light; Male; Mesocricetus; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Time Factors | 2009 |
Plaque deposition dependent decrease in 5-HT2A serotonin receptor in AbetaPPswe/PS1dE9 amyloid overexpressing mice.
Topics: Aging; Amphetamines; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Autoradiography; Citalopram; Data Interpretation, Statistical; Fluorobenzenes; Genes, fos; Head Movements; Humans; In Situ Hybridization; Indicators and Reagents; Male; Mice; Mice, Transgenic; Piperidines; Plaque, Amyloid; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles | 2010 |
Strain-dependent serotonin neuron feedback control: role of serotonin 2C receptors.
Topics: Aminopyridines; Animals; Citalopram; Ethylamines; Extracellular Space; Feedback, Physiological; Fenclonine; gamma-Aminobutyric Acid; Indoles; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Microdialysis; Neurons; Raphe Nuclei; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Species Specificity | 2010 |
5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Attention; beta-Cyclodextrins; Chronic Disease; Citalopram; Cognition; Fluorobenzenes; Male; Microinjections; Pharmaceutical Vehicles; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Reversal Learning; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Set, Psychology; Stress, Psychological | 2012 |
Serotonin 2C receptor antagonists induce fast-onset antidepressant effects.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Chronic Disease; Citalopram; Cyclic AMP Response Element-Binding Protein; Depressive Disorder; Disease Models, Animal; Elongation Factor 2 Kinase; Female; Mice, Inbred BALB C; Olfactory Bulb; Prefrontal Cortex; Pyramidal Cells; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D1; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Stress, Psychological; Time Factors; TOR Serine-Threonine Kinases | 2014 |
5-HT2C receptors in the BNST are necessary for the enhancement of fear learning by selective serotonin reuptake inhibitors.
Topics: Animals; Behavior, Animal; Citalopram; Conditioning, Classical; Cues; Fear; Learning; Male; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Septal Nuclei; Serotonin 5-HT2 Receptor Antagonists; Up-Regulation | 2016 |
Reduction of the serotonin 5-HT
Topics: Aged; Benzamides; Citalopram; Cyclic S-Oxides; Female; Humans; Male; Middle Aged; Piperidones; Pulmonary Artery; Pyridines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Spiro Compounds; Thiadiazines; Vasoconstriction | 2020 |
Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice.
Topics: Aminopyridines; Amphetamines; Animals; Behavior, Animal; Citalopram; Compulsive Behavior; Disease Models, Animal; Female; Fluorobenzenes; Indoles; Mice; Piperidines; Psilocybin; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin Antagonists | 2021 |